Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US.
The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging is correctly labeled as levetiracetam in 0.75% sodium chloride injection 1,000 mg/100 mL.
The pharmaceutical company distributed the batch between Nov. 4 and Nov. 6 to wholesalers, it said, adding that the recall is being taken place under the knowledge of the US Food and Drug Administration.
Dr. Reddy's shares were up 1.3% in recent Thursday trading.
Price: 12.70, Change: +0.17, Percent Change: +1.32
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。